ArticleVeterinary medicine and science2025
Application of Green Cobalt Nanoparticles in the Diet of Broiler Chickens to Improve Sustainable Production and Health.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nutritional Applications of Green Magnesium Nanoparticles as Functional Feed Additives in Broiler Diets: Towards Sustainable Poultry Production.Veterinary medicine and science · 2026Article
- Functional role of manganese nanoparticles in broiler diets: Impacts on growth, antioxidant status, immune response, blood minerals, digestive enzymes, carcass traits, and cecal bacterial counts.Poultry science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundNanoparticles (NPs), such as green cobalt NPs (CoNPs), are easier to pass through cell membranes in animals and interact rapidly with biological systems. Therefore, using green CoNPs is one of the recommendations for enhancing the bioavailability of cobalt, thereby improving its absorption.
objectivesThe goal of this study was to explore the influences of biological nano-cobalt (BNCo) as a feed supplement on broiler growth performance, haematology, blood chemistry, antioxidant activities, immunological status, digestive enzymes and carcass characteristics.
methodsA total of 300 Arbour Acre broiler chicks, all unsexed, were distributed into 5 treatment groups, each containing 60 chicks, at random. Five replications of each group were formed, each containing 12 chicks. The first group received a control diet free of BNCo, whereas the second, third, fourth and fifth groups were administered diets fortified with BNCo at concentrations of 100, 200, 300 and 400 ppm, respectively.
resultsThe results illustrated a significant increase in body weight (p < 0.001), body weight gain (p < 0.001) and improvement in feed conversion ratio (p < 0.01) in comparison to the control diet. BNCo supplementation significantly increased the percentage of immune organs, especially the spleen and thymus (p < 0.05, p < 0.01). Moreover, BNCo supplementation significantly increased haemoglobin (Hb) (p < 0.01), red blood cells (RBCs) (p < 0.05) and white blood cells (WBCs) (p < 0.05). In broiler chickens, BNCo supplementation increased serum levels of total protein, albumin and globulin significantly (p < 0.05) and reduced serum levels of aspartate aminotransferase (AST) activity (p < 0.001) and alanine aminotransaminase (ALT) (p < 0.01). The BNCo in feed supplementation raised blood levels of cobalt and markedly improved lipid markers, immunological and antioxidant status (p < 0.05). Furthermore, digestive enzymes were significantly boosted (p < 0.05) by BNCo treatments.
conclusionThe results indicated that BNCo supplementation at 200 ppm/kg diet produced the best overall performance, demonstrating its potential as an innovative additive for broiler diets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.